🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting news! The National Comprehensive Cancer Network® (National Comprehensive Cancer Network (NCCN) ) released updated Kidney Cancer guidelines (v1.2023) which upgraded AVEO Oncology 's FOTIVDA (tivozanib) to a Category 1 rating. investor.aveooncology.com/news-releases/…

We’re having an interactive uromigos meeting in Nashville 30 Sept-1st Oct Rana McKay, MD, FASCO Matt Galsky Neeraj Agarwal, MD, FASCO Jonathan Rosenberg MD Nick James also on @Prof-Nick-James.bsky.social Sumanta K. Pal, MD, FASCO Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) Shilpa Gupta Petros Grivas Dan George KSridhar details in the podcast anchor.fm/the-uromigos/e…

The #Aveo Team was privileged to participate in 2 fantastic GU oncology weekend conferences, #IKCS in Austin and #DavaOncology #BanffGU2022. Great to catch up with friends & colleagues and absorb all the new science and data that will help more patients with GU malignancies

Great to be back in San Francisco for the annual #ASCOGU conference representing the #AveoOncology team. Always rewarding to re-connect with colleagues, friends and investigators who share the same passion for science and helping patients with GU cancers. #ASCOGU23.

Very proud of Pedro C Barata, MD MSc FACP who worked hard with Alex Chehrazi-Raffle, MD & the AVEO Oncology team (Vijay Kasturi Kim Allman Marge Karas) to resurface data from the RDT of #tivozanib pertaining to non-clear cell #kidneycancer. See his recent paper in The Oncologist here! vaishamu Brian Shuch, MD

AVEO Oncology , an LG Chem company, announced completed enrollment in Phase 3 TiNivo-2 study in patients with RCC. aveooncology.com/aveo-oncology-…

Big news in the #amyloidosis world with the release of top line results for the Phase 3 #acoramidis trial, ATTRIBUTE-CM. Main message: It worked! 🍾 A lot of fascinating history behind this story. What else can we learn from the data? Details to follow… (1/14)

🌟 Today is the day🌏World Amyloidosis Day is here. Let's come together, make our voices heard. Don't forget to take part in the events planned in your country! 🇫🇷🇮🇹🇪🇸🇨🇦🇺🇸🇬🇧🇧🇷🇦🇺🇳🇿🇨🇭🇩🇪🇸🇪 Share with us your photos by using the hashtag #WorldAmyloidosisDay2023 AMYLOIDOSIS ALLIANCE

AVEO Oncology, an LG Chem company, would like to wish everyone a happy and healthy Thanksgiving!  This year we are grateful for our partnership with LG Chem and look forward to a building the future together!

AVEO Oncology, an LG Chem company, wishes everyone a very happy and healthy holiday season! #oncology #biotech #pharma #happyholidays

March is #KidneyCancerAwareness month, recognizing the thousands of people living with kidney cancer worldwide. AVEO Oncology, an LG Chem company, acknowledges the patients and their caregivers affected by this disease, and we thank the kidney cancer patient advocacy groups who

Happy 3rd anniversary, FOTIVDA® (tivozanib)! On March 10, 2021, FOTIVDA received U.S. FDA approval. Three years later, our team at AVEO Oncology, an LG Chem company, still celebrates this important milestone in our company’s history, as we continue to pursue a better life for

AVEO Oncology, an LG Chem company, gathered in our Boston office to #OrangeUp and show our support for #KidneyCancerAwarenessMonth! Each year we observe the month and raise awareness to honor those affected by kidney cancer. #oncology #pharma #biotech #kidneycancer

Beautiful AM for a 5k to start the day at #ESMO2024 OncoAlert Michael Palliola

AVEO Oncology, an LG Chem company, returned from an insightful ESMO - Eur. Oncology European Society for Medical Oncology 2024 congress in Barcelona, Spain. In addition to presenting the late breaking TiNivo-2 clinical study results and a TIVO-3 exploratory post immunotherapy survival

Great way to start final day of #IKCSNA24 with 5 mile run in Louisville with Benjamin L Maughan Michael Palliola

Great time at the #DAVAOncology GU Malignancies Summit in Colorado Springs. Was a neat experience visiting the US Olympic and Paralympic Museum. Awesome to see friends and colleagues and absorb all the new science in GU Cancers.

This Thanksgiving, AVEO Oncology, an LG Chem company, is deeply grateful for our incredible employees, colleagues and partners. Thank you for your support and dedication toward making an impact in the cancer community. We wish everyone a safe and enjoyable holiday.

STRIKE activated; download docs today! Alliance for Clinical Trials in Oncology National Cancer Institute Can we prevent more recurrences with addition of 6 months of Tivozanib to 1 year of pembrolizumab in patients with resected high risk ccRCC? Dan George Jonathan Rosenberg MD Matt Galsky Toni Choueiri, MD